SCOPUS 정보 검색 플랫폼

Volumn 37, Issue 2, 2010, Pages 322-328

The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts

(10) Enjuanes, Anna a Ruiz Gaspà, Silvia a Peris, Pilar a Ozalla, Dolores a Álvarez, Luisa a Combalia, Andrés a Martínez De Osaba, M Jesús a Monegal, Ana a Pares, Albert a Guañabens, Nuria a

a UNIVERSITY OF BARCELONA (Spain)

Author keywords

Alendronate; Osteoprotegerin; Primary human osteoblasts; RANKL

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; MESSENGER RNA; OSTEOCALCIN; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UPREGULATION;

EID: 77952097596 PISSN: 1355008X EISSN: 15590100 Source Type: Journal
DOI: 10.1007/s12020-009-9306-8 Document Type: Article

Times cited : (16)

References (38)

1
- 43049109229
- 10.1007/s00198-007-0540-8 1:CAS:528:DC%2BD1cXltFyjurw%3D 18214569
- RG Russell NB Watts FH Ebetino MJ Rogers 2008 Osteoporos. Int. 19 733 759 10.1007/s00198-007-0540-8 1:CAS:528:DC%2BD1cXltFyjurw%3D 18214569
- (2008) Osteoporos. Int. , vol.19 , pp. 733-759
- Russell, R.G.¹ Watts, N.B.² Ebetino, F.H.³ Rogers, M.J.⁴

2
- 0242503684
- New insights into the molecular mechanisms of action of bisphosphonates
- DOI 10.2174/1381612033453640
- MJ Rogers 2003 Curr. Pharm. Des. 9 2643 2658 10.2174/1381612033453640 1:CAS:528:DC%2BD3sXpsVCkt7Y%3D 14529538 (Pubitemid 37456015)
- (2003) Current Pharmaceutical Design , vol.9 , Issue.32 , pp. 2643-2658
- Rogers, M.J.¹

3
- 0035146537
- 1:CAS:528:DC%2BD3MXoslaluw%3D%3D 11160603
- JE Dunford K Thompson FP Coxon SP Luckman FM Hahn CD Poulter FH Ebetino MJ Rogers 2001 J. Pharmacol. Exp. Ther. 296 235 242 1:CAS:528: DC%2BD3MXoslaluw%3D%3D 11160603
- (2001) J. Pharmacol. Exp. Ther. , vol.296 , pp. 235-242
- Dunford, J.E.¹ Thompson, K.² Coxon, F.P.³ Luckman, S.P.⁴ Hahn, F.M.⁵ Poulter, C.D.⁶ Ebetino, F.H.⁷ Rogers, M.J.⁸

4
- 33646269011
- 10.1359/jbmr.060118 16734383
- JE Dunford MJ Rogers FH Ebetino RJ Phipps FP Coxon 2006 J. Bone Miner. Res. 21 684 694 10.1359/jbmr.060118 16734383
- (2006) J. Bone Miner. Res. , vol.21 , pp. 684-694
- Dunford, J.E.¹ Rogers, M.J.² Ebetino, F.H.³ Phipps, R.J.⁴ Coxon, F.P.⁵

5
- 0031977199
- Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras
- DOI 10.1359/jbmr.1998.13.4.581
- SP Luckman DE Hughes FP Coxon R Graham G Russell MJ Rogers 1998 J. Bone Miner. Res. 13 581 589 10.1359/jbmr.1998.13.4.581 1:CAS:528:DyaK1cXisFyktb8%3D 9556058 (Pubitemid 28163009)
- (1998) Journal of Bone and Mineral Research , vol.13 , Issue.4 , pp. 581-589
- Luckman, S.P.¹ Hughes, D.E.² Coxon, F.P.³ Russell, R.G.G.⁴ Rogers, M.J.⁵

6
- 0033554651
- Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates
- DOI 10.1006/bbrc.1999.1499
- E van Beek E Pieterman L Cohen C Lowik S Papapoulos 1999 Biochem. Biophys. Res. Commun. 264 108 111 10.1006/bbrc.1999.1499 10527849 (Pubitemid 29500472)
- (1999) Biochemical and Biophysical Research Communications , vol.264 , Issue.1 , pp. 108-111
- Van Beek, E.¹ Pieterman, E.² Cohen, L.³ Lowik, C.⁴ Papapoulos, S.⁵

7
- 0036138734
- Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogencontaining bisphosphonates on osteoclast precursors
- DOI 10.1016/S8756-3282(01)00655-X, PII S875632820100655X
- ER Van Beek CW Lowik SE Papapoulos 2002 Bone 30 64 70 10.1016/S8756-3282(01)00655-X 11792566 (Pubitemid 34044302)
- (2002) Bone , vol.30 , Issue.1 , pp. 64-70
- Van Beek, E.R.¹ Lowik, C.W.G.M.² Papapoulos, S.E.³

8
- 33646089442
- 10.1016/j.bone.2005.05.003 1:CAS:528:DC%2BD28XjvFSjtr4%3D 16046206
- GH Nancollas R Tang RJ Phipps Z Henneman S Gulde W Wu A Mangood RG Russell FH Ebetino 2006 Bone 38 617 627 10.1016/j.bone.2005.05.003 1:CAS:528:DC%2BD28XjvFSjtr4%3D 16046206
- (2006) Bone , vol.38 , pp. 617-627
- Nancollas, G.H.¹ Tang, R.² Phipps, R.J.³ Henneman, Z.⁴ Gulde, S.⁵ Wu, W.⁶ Mangood, A.⁷ Russell, R.G.⁸ Ebetino, F.H.⁹

9
- 41049084067
- 10.1007/s00223-008-9104-y 1:CAS:528:DC%2BD1cXjsF2gt70%3D 18259679
- AI Idris J Rojas IR Greig RJ Van't Hof SH Ralston 2008 Calcif. Tissue Int. 82 191 201 10.1007/s00223-008-9104-y 1:CAS:528:DC%2BD1cXjsF2gt70%3D 18259679
- (2008) Calcif. Tissue Int. , vol.82 , pp. 191-201
- Idris, A.I.¹ Rojas, J.² Greig, I.R.³ Van'T Hof, R.J.⁴ Ralston, S.H.⁵

10
- 0028851590
- 10.1056/NEJM199511303332201 1:CAS:528:DyaK28XkslehtA%3D%3D 7477143
- UA Liberman SR Weiss J Broll HW Minne H Quan NH Bell J Rodriguez-Portales RW Jr Downs J Dequeker M Favus 1995 N. Engl. J. Med. 333 1437 1443 10.1056/NEJM199511303332201 1:CAS:528:DyaK28XkslehtA%3D%3D 7477143
- (1995) N. Engl. J. Med. , vol.333 , pp. 1437-1443
- Liberman, U.A.¹ Weiss, S.R.² Broll, J.³ Minne, H.W.⁴ Quan, H.⁵ Bell, N.H.⁶ Rodriguez-Portales, J.⁷ Jr Downs, R.W.⁸ Dequeker, J.⁹ Favus, M.¹⁰

11
- 0034530951
- Fracture risk reduction with alendronate in women with osteoporosis: The fractureintervention trial
- DOI 10.1210/jc.85.11.4118
- DM Black DE Thompson DC Bauer K Ensrud T Musliner MC Hochberg MC Nevitt S Suryawanshi SR Cummings 2000 J. Clin. Endocrinol. Metab. 85 4118 4124 10.1210/jc.85.11.4118 1:CAS:528:DC%2BD3cXotlWnurw%3D 11095442 (Pubitemid 32055362)
- (2000) Journal of Clinical Endocrinology and Metabolism , vol.85 , Issue.11 , pp. 4118-4124
- Black, D.M.¹ Thompson, D.E.² Bauer, D.C.³ Ensrud, K.⁴ Musliner, T.⁵ Hochberg, M.C.⁶ Nevitt, M.C.⁷ Suryawanshi, S.⁸ Cummings, S.R.⁹

12
- 0036677983
- II. Meta-analysis of alendronate for the treatment of postmenopausal women
- DOI 10.1210/er.2001-2002
- A Cranney G Wells A Willan L Griffith N Zytaruk V Robinson D Black J Adachi B Shea P Tugwell G Guyatt Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group 2002 Endocr. Rev. 23 508 516 10.1210/er.2001-2002 1:CAS:528:DC%2BD38Xnt1Wiur8%3D 12202465 (Pubitemid 34925644)
- (2002) Endocrine Reviews , vol.23 , Issue.4 , pp. 508-516
- Cranney, A.¹ Wells, G.² Willan, A.³ Griffith, L.⁴ Zytaruk, N.⁵ Robinson, V.⁶ Black, D.⁷ Adachi, J.⁸ Shea, B.⁹ Tugwell, P.¹⁰ Guyatt, G.¹¹

13
- 0042769062
- Alendronate and etidronate do not regulate interleukin 6 and 11 synthesis in normal human osteoblasts in culture
- DOI 10.1007/s00223-001-2136-1
- E Engel S Serrano ML Marinoso J Lloreta F Ulloa X Nogués A Diez-Pérez J Carbonell 2003 Calcif. Tissue Int. 72 228 235 10.1007/s00223-001-2136-1 1:CAS:528:DC%2BD3sXitFCgtrk%3D 12522661 (Pubitemid 36919528)
- (2003) Calcified Tissue International , vol.72 , Issue.3 , pp. 228-235
- Engel, E.¹ Serrano, S.² Marinoso, M.L.³ Lloreta, J.⁴ Ulloa, F.⁵ Nogues, X.⁶ Diez-Perez, A.⁷ Carbonell, J.⁸

14
- 0037204816
- 1:CAS:528:DC%2BD38XkvV2gtbk%3D 12085990
- YH Kim GS Kim B Jeong-Hwa 2002 Exp. Mol. Med. 34 145 151 1:CAS:528:DC%2BD38XkvV2gtbk%3D 12085990
- (2002) Exp. Mol. Med. , vol.34 , pp. 145-151
- Kim, Y.H.¹ Kim, G.S.² Jeong-Hwa, B.³

15
- 0036295812
- Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts
- DOI 10.1006/bbrc.2002.6510
- V Viereck G Emons V Lauck KH Frosch S Blaschke C Gründker LC Hofbauer 2002 Biochem. Biophys. Res. Commun. 291 680 686 10.1006/bbrc.2002.6510 1:CAS:528:DC%2BD38XhtlGmu78%3D 11855844 (Pubitemid 34687400)
- (2002) Biochemical and Biophysical Research Communications , vol.291 , Issue.3 , pp. 680-686
- Viereck, V.¹ Emons, G.² Lauck, V.³ Frosch, K.-H.⁴ Blaschke, S.⁵ Grundker, C.⁶ Hofbauer, L.C.⁷

16
- 0029934545
- Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast- mediated resorption
- DOI 10.1210/en.137.6.2324
- C Vitte H Fleisch HL Guenther 1996 Endocrinology 137 2324 2333 10.1210/en.137.6.2324 1:CAS:528:DyaK28XjtFWrt7c%3D 8641182 (Pubitemid 26155765)
- (1996) Endocrinology , vol.137 , Issue.6 , pp. 2324-2333
- Vitte, C.¹ Fleisch, H.² Guenther, H.L.³

17
- 42749083246
- 10.1016/j.abb.2008.03.018 1:CAS:528:DC%2BD1cXlsFOgt7c%3D 18395508
- BF Boyce L Xing 2008 Arch. Biochem. Biophys. 473 139 146 10.1016/j.abb.2008.03.018 1:CAS:528:DC%2BD1cXlsFOgt7c%3D 18395508
- (2008) Arch. Biochem. Biophys. , vol.473 , pp. 139-146
- Boyce, B.F.¹ Xing, L.²

18
- 42049110350
- Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease
- DOI 10.1210/er.2007-0014
- AE Kearns S Khosla PJ Kostenuik 2008 Endocr. Rev. 29 155 192 10.1210/er.2007-0014 1:CAS:528:DC%2BD1cXltlOhsr0%3D 18057140 (Pubitemid 351519689)
- (2008) Endocrine Reviews , vol.29 , Issue.2 , pp. 155-192
- Kearns, A.E.¹ Khosla, S.² Kostenuik, P.J.³

19
- 0037644721
- Biology of the TRANCE axis
- DOI 10.1016/S1359-6101(03)00027-3
- MC Walsh Y Choi 2003 Cytokine Growth Factor Rev. 14 251 263 10.1016/S1359-6101(03)00027-3 1:CAS:528:DC%2BD3sXkt1GhsrY%3D 12787563 (Pubitemid 36693145)
- (2003) Cytokine and Growth Factor Reviews , vol.14 , Issue.3-4 , pp. 251-263
- Walsh, M.C.¹ Choi, Y.²

20
- 0035987949
- 1:CAS:528:DC%2BD38Xls1aqtLo%3D 12109626
- O Fromigue JJ Body 2002 J. Endocrinol. Invest. 25 539 546 1:CAS:528:DC%2BD38Xls1aqtLo%3D 12109626
- (2002) J. Endocrinol. Invest. , vol.25 , pp. 539-546
- Fromigue, O.¹ Body, J.J.²

21
- 44949207294
- 10.1016/j.bone.2008.03.008 1:CAS:528:DC%2BD1cXnt1amsbk%3D 18486585
- L Fu T Tang Y Miao S Zhang Z Qu K Dai 2008 Bone 43 40 47 10.1016/j.bone.2008.03.008 1:CAS:528:DC%2BD1cXnt1amsbk%3D 18486585
- (2008) Bone , vol.43 , pp. 40-47
- Fu, L.¹ Tang, T.² Miao, Y.³ Zhang, S.⁴ Qu, Z.⁵ Dai, K.⁶

22
- 0032031289
- Effect of alendronate on cultured normal human osteoblasts
- DOI 10.1016/S8756-3282(97)00270-6, PII S8756328297002706
- C Garcia-Moreno S Serrano M Nacher M Farré A Díez ML Mariñoso J Carbonell L Mellibovsky X Nogués J Ballester J Aubía 1998 Bone 22 233 239 10.1016/S8756-3282(97)00270-6 1:CAS:528:DyaK1cXitVGktrc%3D 9580147 (Pubitemid 28127478)
- (1998) Bone , vol.22 , Issue.3 , pp. 233-239
- Garcia-Moreno, C.¹ Serrano, S.² Nacher, M.³ Farre, M.⁴ Diez, A.⁵ Marinoso, M.L.⁶ Carbonell, J.⁷ Mellibovsky, L.⁸ Nogues, X.⁹ Ballester, J.¹⁰ Aubia, J.¹¹

23
- 0031979896
- Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo
- DOI 10.1016/S8756-3282(98)00033-7, PII S8756328298000337
- N Giuliani M Pedrazzoni G Negri G Passeri M Impicciatore G Girasole 1998 Bone 22 455 461 10.1016/S8756-3282(98)00033-7 1:CAS:528:DyaK1cXjtVKntbY%3D 9600778 (Pubitemid 28226858)
- (1998) Bone , vol.22 , Issue.5 , pp. 455-461
- Giuliani, N.¹ Pedrazzoni, M.² Negri, G.³ Passeri, G.⁴ Impicciatore, M.⁵ Girasole, G.⁶

24
- 1642306206
- Osteoblast proliferation and maturation by bisphosphonates
- DOI 10.1016/j.biomaterials.2003.11.024, PII S0142961203010883
- GI Im SA Qureshi J Kenney HE Rubash AS Shanbhag 2004 Biomaterials 25 4105 4115 10.1016/j.biomaterials.2003.11.024 1:CAS:528:DC%2BD2cXitlWqsLs%3D 15046901 (Pubitemid 38388576)
- (2004) Biomaterials , vol.25 , Issue.18 , pp. 4105-4115
- Im, G.-I.¹ Qureshi, S.A.² Kenney, J.³ Rubash, H.E.⁴ Shanbhag, A.S.⁵

25
- 1642395138
- Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures
- DOI 10.1016/j.ejphar.2003.08.011, PII S0014299903022052
- F Itoh S Aoyagi H Furihata-Komatsu M Aoki H Kusama M Kojima H Kogo 2003 Eur. J. Pharmacol. 477 9 16 10.1016/j.ejphar.2003.08.011 1:CAS:528: DC%2BD3sXnsVamtro%3D 14512092 (Pubitemid 38366079)
- (2003) European Journal of Pharmacology , vol.477 , Issue.1 , pp. 9-16
- Itoh, F.¹ Aoyagi, S.² Furihata-Komatsu, H.³ Aoki, M.⁴ Kusama, H.⁵ Kojima, M.⁶ Kogo, H.⁷

26
- 0034326253
- 1:CAS:528:DC%2BD3cXotV2ls7g%3D 11085520
- GG Reinholz B Getz L Pederson ES Sanders M Subramaniam JN Ingle TC Spelsberg 2000 Cancer Res. 60 6001 6007 1:CAS:528:DC%2BD3cXotV2ls7g%3D 11085520
- (2000) Cancer Res. , vol.60 , pp. 6001-6007
- Reinholz, G.G.¹ Getz, B.² Pederson, L.³ Sanders, E.S.⁴ Subramaniam, M.⁵ Ingle, J.N.⁶ Spelsberg, T.C.⁷

27
- 0034773199
- 10.1359/jbmr.2001.16.11.2050 1:CAS:528:DC%2BD3MXot12lsb8%3D 11697801
- I Mathov LI Plotkin CL Sgarlata J Leoni T Bellido 2001 J. Bone Miner. Res. 16 2050 2056 10.1359/jbmr.2001.16.11.2050 1:CAS:528:DC%2BD3MXot12lsb8%3D 11697801
- (2001) J. Bone Miner. Res. , vol.16 , pp. 2050-2056
- Mathov, I.¹ Plotkin, L.I.² Sgarlata, C.L.³ Leoni, J.⁴ Bellido, T.⁵

28
- 38449112480
- Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells
- DOI 10.1359/jbmr.070701
- G Duque D Rivas 2007 J. Bone Miner. Res. 22 1603 1611 10.1359/jbmr.070701 1:CAS:528:DC%2BD2sXhtFyhu7bO 17605634 (Pubitemid 351229330)
- (2007) Journal of Bone and Mineral Research , vol.22 , Issue.10 , pp. 1603-1611
- Duque, G.¹ Rivas, D.²

29
- 0033747980
- 10.1067/mlc.2000.109757 1:CAS:528:DC%2BD3cXosFygsLw%3D 11079461
- Y Abe A Kawakami T Nakashima E Ejima K Fujiyama T Kiriyama A Ide N Sera T Usa T Tominaga K Ashizawa N Yokoyama K Eguchi 2000 J. Lab. Clin. Med. 136 344 354 10.1067/mlc.2000.109757 1:CAS:528:DC%2BD3cXosFygsLw%3D 11079461
- (2000) J. Lab. Clin. Med. , vol.136 , pp. 344-354
- Abe, Y.¹ Kawakami, A.² Nakashima, T.³ Ejima, E.⁴ Fujiyama, K.⁵ Kiriyama, T.⁶ Ide, A.⁷ Sera, N.⁸ Usa, T.⁹ Tominaga, T.¹⁰ Ashizawa, K.¹¹ Yokoyama, N.¹² Eguchi, K.¹³

30
- 45949086844
- 10.1016/j.tripleo.2008.03.036 18504149
- A Naidu PC Dechow R Spears JM Wright HP Kessler LA Opperman 2008 Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 106 5 13 10.1016/j.tripleo. 2008.03.036 18504149
- (2008) Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. , vol.106 , pp. 5-13
- Naidu, A.¹ Dechow, P.C.² Spears, R.³ Wright, J.M.⁴ Kessler, H.P.⁵ Opperman, L.A.⁶

31
- 33751145145
- 10.3109/15419060109080757 1:CAS:528:DC%2BD38XltVSqtLY%3D
- LI Plotkin T Bellido 2001 Cell Adhes. Commun. 8 377 382 10.3109/15419060109080757 1:CAS:528:DC%2BD38XltVSqtLY%3D
- (2001) Cell Adhes. Commun. , vol.8 , pp. 377-382
- Plotkin, L.I.¹ Bellido, T.²

32
- 33746768764
- Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs
- DOI 10.1016/j.bone.2006.02.060, PII S8756328206003267
- LI Plotkin SC Manolagas T Bellido 2006 Bone 39 443 452 10.1016/j.bone.2006.02.060 1:CAS:528:DC%2BD28XotFyksLg%3D 16627025 (Pubitemid 44164640)
- (2006) Bone , vol.39 , Issue.3 , pp. 443-452
- Plotkin, L.I.¹ Manolagas, S.C.² Bellido, T.³

33
- 0032722149
- 10.1172/JCI6800 1:CAS:528:DyaK1MXntlyru7k%3D 10562298
- LI Plotkin RS Weinstein AM Parfitt PK Roberson SC Manolagas T Bellido 1999 J. Clin. Invest. 104 1363 1374 10.1172/JCI6800 1:CAS:528:DyaK1MXntlyru7k%3D 10562298
- (1999) J. Clin. Invest. , vol.104 , pp. 1363-1374
- Plotkin, L.I.¹ Weinstein, R.S.² Parfitt, A.M.³ Roberson, P.K.⁴ Manolagas, S.C.⁵ Bellido, T.⁶

34
- 0037215365
- 3 on parathyroid hormone-related protein expression in human osteoblastic cells
- DOI 10.1359/jbmr.2003.18.1.78
- L Gomez-Garcia P Esbrit L Carreno P Sabando M García-Flores ME Martinez 2003 J. Bone Miner. Res. 18 78 87 10.1359/jbmr.2003.18.1.78 1:CAS:528:DC%2BD3sXltFKlug%3D%3D 12510808 (Pubitemid 36008342)
- (2003) Journal of Bone and Mineral Research , vol.18 , Issue.1 , pp. 78-87
- Gomez-Garcia, L.¹ Esbrit, P.² Carreno, L.³ Sabando, P.⁴ Garcia-Flores, M.⁵ Martinez, M.E.⁶

35
- 0031595156
- Alendronate/interleukin-1β cotreatment increases interleukin-6 in bone and UMR-106 cells: Dose dependence and relationship to the antiresorptive effect of alendronate
- DOI 10.1359/jbmr.1998.13.5.786
- JL Sanders G Tarjan SA Foster PH Stern 1998 J. Bone Miner. Res. 13 786 792 10.1359/jbmr.1998.13.5.786 1:CAS:528:DyaK1cXjsVaquro%3D 9610742 (Pubitemid 28224194)
- (1998) Journal of Bone and Mineral Research , vol.13 , Issue.5 , pp. 786-792
- Sanders, J.L.¹ Tarjan, G.² Foster, S.A.³ Stern, P.H.⁴

36
- 33646390686
- 10.1007/BF02968579 1:CAS:528:DC%2BD28XltF2gt7k%3D 16681040
- MH Yun JS Woo KI Kwon 2006 Arch. Pharm. Res. 29 328 332 10.1007/BF02968579 1:CAS:528:DC%2BD28XltF2gt7k%3D 16681040
- (2006) Arch. Pharm. Res. , vol.29 , pp. 328-332
- Yun, M.H.¹ Woo, J.S.² Kwon, K.I.³

37
- 0022256585
- Human bone cells in vitro
- DOI 10.1007/BF02557826
- PG Robey JD Termine 1985 Calcif. Tissue Int. 37 453 460 10.1007/BF02557826 1:STN:280:DyaL28%2Flt1yhsQ%3D%3D 2998572 (Pubitemid 15250110)
- (1985) Calcified Tissue International , vol.37 , Issue.5 , pp. 453-460
- Gehron Robey, P.¹ Termine, J.D.²

38
- 17944399162
- Immunocytochemical evidence on the effects of glucocorticoids on type I collagen synthesis in human osteoblastic cells
- DOI 10.1007/s00223-002-1095-5
- MV Hernandez N Guanabens L Alvarez A Monegal P Peris J Riba G Ercilla MJ Martínez de Osaba J Muñoz-Gómez 2004 Calcif. Tissue Int. 74 284 293 10.1007/s00223-002-1095-5 1:CAS:528:DC%2BD2cXjt1SlurY%3D 14583839 (Pubitemid 38339579)
- (2004) Calcified Tissue International , vol.74 , Issue.3 , pp. 284-293
- Hernandez, M.V.¹ Guanabens, N.² Alvarez, L.³ Monegal, A.⁴ Peris, P.⁵ Riba, J.⁶ Ercilla, G.⁷ Martinez De Osaba, M.J.⁸ Munoz-Gomez, J.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.